NewAmsterdam Pharma Corporation
NewAmsterdam Pharma Corporation is a clinical-stage biopharma company creating therapies for cardiometabolic diseases.
102 employees · est. 2019 · Aventura, United States
Gemphire Therapeutics is the older company (2011 vs 2019); NewAmsterdam Pharma Corporation is the larger of the two.
Side-by-Side Comparison
| Metric | Gemphire Therapeutics | NewAmsterdam Pharma Corporation |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2019 |
| Headquarters | ||
| Headquarters | Livonia, United States | Aventura, United States |
| Employees | ||
| Employees | 1 | 102 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Manufacturing | Biotechnology, Life Sciences, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Private Equity | IPO |
| Total Funding | ||
| Total Funding | $18.40M | $907.90M |
| Funding Rounds | ||
| Funding Rounds | 4 | 6 |
| Services | ||
| Services | Not tracked yet | Cardiovascular Disease Research, Development of Obicetrapib, Clinical Science on CETP Inhibition, Inducement Grants |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with High Cholesterol, Healthcare Providers, Cardiovascular Disease Patients, Research Institutions |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Dyslipidemia Treatment, Gemcabene, Clinical Stage, Lipid-lowering Therapy, Cardiovascular Disease, VLDL Clearance, Cholesterol Inhibition, NASH Treatment, NAFLD Treatment, Clinical Trials, Lipid Metabolism, Cardiovascular Risk, Triglyceride Reduction, Liver Disease | Biopharmaceuticals, Clinical-stage Development, Cardiometabolic Diseases, Transformative Therapies, Cholesteryl Ester Transfer Protein Inhibitor, LDL-C Lowering Therapy, Lipid-lowering Therapy, Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Patient Care Improvement, Statin Therapy, Late-stage Clinical Trials |
| Website | ||
| Website | gemphire.com | newamsterdampharma.com |
About Gemphire Therapeutics
Gemphire Therapeutics is a **clinical stage biopharmaceutical company** founded in 2014, headquartered in the United States. The company's focus lies in developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition increasing the risk of life-threatening car...
About NewAmsterdam Pharma Corporation
NewAmsterdam Pharma Corporation is capturing the attention of the biopharma sector through its commitment to addressing unmet needs in cardiometabolic diseases. Established in 2019, this United States-based company is actively engaged in late-stage clinical trials. The company's primary focus is on...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Gemphire Therapeutics and NewAmsterdam Pharma Corporation — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Gemphire Therapeutics and NewAmsterdam Pharma Co... — by email.
Frequently Asked Questions
Compare Gemphire Therapeutics with someone else
Start typing a company name or domain.